123 related articles for article (PubMed ID: 17641012)
1. Xenogeneic beta 2-microglobulin substitution alters NK cell function.
Benoît LA; Tan R
J Immunol; 2007 Aug; 179(3):1466-74. PubMed ID: 17641012
[TBL] [Abstract][Full Text] [Related]
2. Influence of xenogeneic beta2-microglobulin on functional recognition of H-2Kb by the NK cell inhibitory receptor Ly49C.
Benoit LA; Shannon J; Chamberlain JW; Miller RG
J Immunol; 2005 Sep; 175(6):3542-53. PubMed ID: 16148097
[TBL] [Abstract][Full Text] [Related]
3. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
Maeda M; Shadeo A; MacFadyen AM; Takei F
J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
5. Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.
Choi T; Ferris ST; Matsumoto N; Poursine-Laurent J; Yokoyama WM
J Immunol; 2011 Apr; 186(7):3911-7. PubMed ID: 21335486
[TBL] [Abstract][Full Text] [Related]
6. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
Grigoriadou K; Ménard C; Pérarnau B; Lemonnier FA
Eur J Immunol; 1999 Nov; 29(11):3683-90. PubMed ID: 10556824
[TBL] [Abstract][Full Text] [Related]
7. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex genes determine natural killer cell tolerance.
Dorfman JR; Raulet DH
Eur J Immunol; 1996 Jan; 26(1):151-5. PubMed ID: 8566058
[TBL] [Abstract][Full Text] [Related]
9. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
10. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells.
Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG
J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
[TBL] [Abstract][Full Text] [Related]
12. Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro.
Kambayashi T; Michaëlsson J; Fahlén L; Chambers BJ; Sentman CL; Kärre K; Ljunggren HG
Eur J Immunol; 2001 Mar; 31(3):869-75. PubMed ID: 11241292
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
14. NK cell tolerance in mixed allogeneic chimeras.
Zhao Y; Ohdan H; Manilay JO; Sykes M
J Immunol; 2003 Jun; 170(11):5398-405. PubMed ID: 12759414
[TBL] [Abstract][Full Text] [Related]
15. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
16. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice.
Salcedo M; Andersson M; Lemieux S; Van Kaer L; Chambers BJ; Ljunggren HG
Eur J Immunol; 1998 Apr; 28(4):1315-21. PubMed ID: 9565371
[TBL] [Abstract][Full Text] [Related]
17. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis.
Chiang EY; Henson M; Stroynowski I
J Immunol; 2002 Mar; 168(5):2200-11. PubMed ID: 11859106
[TBL] [Abstract][Full Text] [Related]
18. Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.
Sullivan LC; Berry R; Sosnin N; Widjaja JM; Deuss FA; Balaji GR; LaGruta NL; Mirams M; Trapani JA; Rossjohn J; Brooks AG; Andrews DM
J Biol Chem; 2016 Sep; 291(36):18740-52. PubMed ID: 27385590
[TBL] [Abstract][Full Text] [Related]
19. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
20. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
